Popular search terms:
Search Results
45 results found-
CSL Behring provides protein-based therapies for bleeding disorders, critical care, pulmonary disease, and other rare illnesses.
https://www.cslbehring.com.au/products -
CSL Behring Australia's Product Information (PI), Consumer Medicine Information (CMI), Safety Data Sheets and New Zealand Data Sheet
https://www.cslbehring.com.au/products/products-list -
CSL's Australian Graduate Program is a two-year program focused on providing you with career opportunities within our 'CSL Behring' and 'CSL Seqirus' global businesses.
https://www.cslbehring.com.au/careers/graduate-program/graduate-streams -
In congenital deficiency of any of the vitamin K dependent factors, specific coagulation factor products should be used when available.
https://www.cslbehring.com.au/-/media/cslb-australia/documents/aus-pis-and-cmis/beriplex-au-toll-pi-v300.pdf -
CSL's Australian Internship Program is a 10-week paid internship, offering hands-on experience with a global leader.
https://www.cslbehring.com.au/careers/internship-program/internship-streams -
Social Media Community Guidelines for CSL Behring Corporate Channels
https://www.cslbehring.com.au/social-guidelines -
CSL Behring is a global biotech company leading the way to deliver innovative therapies for rare and serious diseases.
https://www.cslbehring.com.au/our-company -
Hazard(s) identification Not classified as hazardous according to the WHS Regulations All blood products should be treated as potentially infectious.
https://www.cslbehring.com.au/-/media/cslb-austria/documents/sds262-riastap-v2.pdf